Beare-stevenson Cutis Gyrata Syndrome
Disease Details
Family Health Simplified
- Description
- Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder characterized by craniosynostosis (premature fusion of skull bones) and distinctive skin abnormalities, including grooved or ridged skin.
- Type
- Beare-Stevenson cutis gyrata syndrome is a genetic disorder classified under craniosynostosis syndromes. It is transmitted in an autosomal dominant manner.
- Signs And Symptoms
-
Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder. Here are the signs and symptoms:
1. **Craniosynostosis**: Premature fusion of skull bones leading to an abnormal head shape.
2. **Cutis Gyrata**: Furrowed and thickened skin, typically on the face and scalp.
3. **Skin Abnormalities**: Acanthosis nigricans (dark, thickened patches of skin).
4. **Face Features**: Prominent ears, a wide nose, and a flat midface.
5. **Visual Problems**: Proptosis (bulging eyes), and other eye abnormalities.
6. **Hearing Issues**: Hearing loss due to ear abnormalities.
7. **Genital Abnormalities**: In some cases, abnormalities in the genital area.
8. **Delayed Development**: Potential developmental delays and intellectual disability.
The syndrome is caused by mutations in the FGFR2 gene and is inherited in an autosomal dominant pattern. - Prognosis
- Beare-Stevenson Cutis Gyrata Syndrome is a very rare genetic disorder. The prognosis is generally poor due to the presence of multiple severe congenital anomalies. Affected individuals often suffer from life-threatening complications, especially related to airway management, craniofacial abnormalities, and neurological impairments. Early intervention and multi-disciplinary management may improve the quality of life, but life expectancy is typically reduced.
- Onset
- Beare-Stevenson cutis gyrata syndrome typically presents at birth.
- Prevalence
- Beare-Stevenson cutis gyrata syndrome is an extremely rare genetic disorder. Its exact prevalence is not well-documented, but it has been reported in only a small number of cases worldwide.
- Epidemiology
- Beare-Stevenson cutis gyrata syndrome is an extremely rare genetic disorder. Exact epidemiological data are not well-documented due to the rarity of the condition, with only a few dozen cases reported in medical literature. This syndrome is typically caused by a specific mutation in the FGFR2 gene and is inherited in an autosomal dominant manner.
- Intractability
- Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder that is generally considered intractable because it results from mutations in the FGFR2 gene, which affects development. There is no cure for the condition, and treatment is primarily symptomatic and supportive, focusing on managing the individual features and complications of the syndrome.
- Disease Severity
- Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder characterized by premature fusion of certain skull bones (craniosynostosis) and distinctive skin abnormalities, such as furrowed and wrinkled skin. The disease severity can vary, but it often leads to serious complications, including developmental delays, intellectual disabilities, and life-threatening medical issues. The condition is generally severe and requires comprehensive medical care.
- Healthcare Professionals
- Disease Ontology ID - DOID:0050660
- Pathophysiology
-
Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder characterized by distinctive skin and skull abnormalities.
**Pathophysiology:**
The condition is caused by mutations in the FGFR2 (fibroblast growth factor receptor 2) gene. These mutations lead to abnormal signaling in cells that are critical for skin and bone development, resulting in the characteristic features such as furrowed and wrinkled skin (cutis gyrata), craniosynostosis (premature fusion of skull bones), and other associated anomalies.
**nan:**
The abbreviation "nan" possibly indicates the absence of data or not applicable contexts. If it's intended to request specific data (such as "not a number"), additional context would be necessary to provide a relevant response. - Carrier Status
- Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder caused by mutations in the FGFR2 gene. Carrier status is not typically applicable for this autosomal dominant disorder, meaning an affected individual has one mutated copy of the gene. Carriers of recessive disorders would typically not show symptoms, but in dominant disorders like Beare-Stevenson syndrome, a single copy of the mutation is sufficient to cause the condition.
- Mechanism
-
Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder characterized by distinctive skin and skull abnormalities. The primary mechanism involves mutations in the FGFR2 (fibroblast growth factor receptor 2) gene.
Molecular Mechanisms:
1. **FGFR2 Mutation**: The FGFR2 gene provides instructions for making a protein that is involved in cell division, growth, maturation, formation of blood vessels, wound healing, and embryonic development.
2. **Constitutive Activation**: Mutations in FGFR2 lead to a receptor that is either constitutively active or has altered binding, resulting in prolonged and inappropriate activation of signaling pathways. This disrupts normal cellular processes.
3. **Aberrant Signal Transduction**: The abnormal FGFR2 signaling affects developmental processes, particularly those involving skin and bone development, leading to the characteristic features of the syndrome, such as cutis gyrata (furrowed skin) and craniosynostosis (premature fusion of skull bones).
Understanding these molecular mechanisms is crucial for grasping how the syndrome manifests and potentially guiding therapeutic interventions. - Treatment
- Beare-Stevenson Cutis Gyrata Syndrome is a rare genetic disorder. Treatment is primarily symptomatic and supportive, aiming to address the specific symptoms experienced by each individual. This may involve surgical procedures to correct craniofacial abnormalities, ongoing monitoring by a team of specialists, and supportive therapies such as speech and occupational therapy. Genetic counseling may also be beneficial for affected families. No cure exists, so management focuses on improving the quality of life and addressing medical issues as they arise.
- Compassionate Use Treatment
-
Beare-Stevenson cutis gyrata syndrome is an extremely rare genetic disorder, and there are no specific treatments approved specifically for this condition. Management primarily involves addressing the symptoms and complications associated with the syndrome. Here are a few approaches:
1. **Supportive Care**: Symptom management through multidisciplinary care involving dermatology, neurology, plastic surgery, and other specialties as needed.
2. **Experimental Treatments**: Participation in clinical trials, if available, could be an option to explore new therapeutic approaches. Families can consult with medical professionals to determine eligibility for such trials.
3. **Compassionate Use**: Access to investigational treatments outside clinical trials, known as compassionate use, might be considered in severe cases. This typically involves an application process and approval from regulatory bodies.
4. **Off-label Use**: Some medications or interventions may be used off-label to manage symptoms, although specific examples for Beare-Stevenson cutis gyrata syndrome are not well-documented due to its rarity.
Families should work closely with geneticists and specialized healthcare providers to explore these options and determine the best individualized care plan. - Lifestyle Recommendations
-
Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder characterized by skin abnormalities, craniofacial anomalies, and other physical features. Given its rarity and complexity, individualized medical care is crucial. However, general lifestyle recommendations include:
1. **Regular Medical Follow-ups**: Frequent consultations with specialists such as pediatricians, dermatologists, and geneticists to monitor and manage symptoms.
2. **Skin Care**: Specialized skin care routines to manage cutis gyrata (thickened, ridged skin) and prevent secondary infections.
3. **Nutrition**: A balanced diet to support overall health and development.
4. **Physical Therapy**: Engaging in physical therapy to improve mobility and strengthen muscles, particularly if developmental delays are present.
5. **Supportive Devices**: Utilizing adaptive devices as needed to improve quality of life, such as corrective helmets for craniofacial anomalies.
6. **Educational Support**: Early intervention and special education resources to support developmental and learning needs.
7. **Mental Health**: Access to psychological support for both the individual and their family to cope with the emotional and social aspects of the syndrome.
Consulting with a healthcare provider for personalized advice is essential. - Medication
- Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder typically caused by mutations in the FGFR2 gene. It is characterized by skin abnormalities and craniofacial malformations. There is no specific medication for treating this syndrome. Management typically involves supportive care and addressing individual symptoms, which may include surgical interventions for craniofacial abnormalities. Coordination with a multidisciplinary team of specialists, such as geneticists, dermatologists, and surgeons, is often necessary to address the various aspects of the condition.
- Repurposable Drugs
- There are currently no specific repurposable drugs identified for Beare-Stevenson cutis gyrata syndrome. This rare genetic disorder is typically addressed through symptom management and supportive care. It is crucial for patients to consult with a healthcare professional for personalized treatment options and guidance.
- Metabolites
- Beare-Stevenson cutis gyrata syndrome is a genetic disorder caused by mutations in the FGFR2 gene. There is no specific information available regarding unique or altered metabolites associated with this condition. It primarily affects the skin, skull, and facial structures, leading to characteristic physical abnormalities rather than metabolic dysfunctions.
- Nutraceuticals
- Beare-Stevenson cutis gyrata syndrome is a rare genetic disorder caused by mutations in the FGFR2 gene. There is no specific evidence or research supporting the use of nutraceuticals in treating or managing this syndrome. Treatment typically focuses on addressing the physical symptoms and complications through surgical interventions and supportive care. Always consult with a healthcare provider for personalized medical advice.
- Peptides
- Beare-Stevenson Cutis Gyrata Syndrome is a rare genetic disorder characterized by abnormal skin and cranial features. It is caused by mutations in the FGFR2 gene. There is no specific information linking peptides and this syndrome directly. Further research or context is needed to establish any connection between peptides and the management or pathology of Beare-Stevenson Cutis Gyrata Syndrome.